Genes Tech Group Holdings Company Limited (08257) released its monthly return for February 2026 regarding movements in securities. The authorized share capital remained at 2.00 billion ordinary shares, each with a par value of HKD 0.01. This amounted to an authorized share capital of HKD 20.00 million at the end of the reporting period.

The company reported that the total number of issued shares stayed at 1.00 billion, with no treasury shares in issue. The relevant public float requirement of 25% continued to be met. No changes occurred in listed share options, though there is a potential for 100.00 million shares under the Share Option Scheme adopted on 20 June 2017, with no issuance or transfer of treasury shares during February 2026.